Loss of p53 attenuates the contribution of IL-6 deletion on suppressed tumor progression and extended survival in Kras-driven murine lung cancer
about
Proteomic-Based Approaches for the Study of Cytokines in Lung CancerTargeting pathways downstream of KRAS in lung adenocarcinoma.The chemokine CXCL13 in lung cancers associated with environmental polycyclic aromatic hydrocarbons pollution.IL6 Blockade Reprograms the Lung Tumor Microenvironment to Limit the Development and Progression of K-ras-Mutant Lung Cancer.Bronchial Artery Angiogenesis Drives Lung Tumor Growth.Progression inference for somatic mutations in cancer.Quercetin inhibits multiple pathways involved in interleukin 6 secretion from human lung fibroblasts and activity in bronchial epithelial cell transformation induced by benzo[a]pyrene diol epoxide.Inflammation as a driver and vulnerability of KRAS mediated oncogenesisRIP4 inhibits STAT3 signaling to sustain lung adenocarcinoma differentiation.Regulation of autophagy inhibition and inflammatory response in glioma by Wnt signaling pathway.Identifying genes as potential prognostic indicators in patients with serous ovarian cancer resistant to carboplatin using integrated bioinformatics analysis.Molecular cross-talk of IL-6 in tumors and new progress in combined therapy.Targeting cytokine networks in KRAS-driven tumorigenesis.Outcome analysis of Phase I trial patients with metastatic and/or mutant non-small cell lung cancer
P2860
Q26738539-119A5DA5-55F2-4F9A-9FE7-FED2EAE36C77Q30597330-C0AB25E1-2135-47FD-B30D-5B4C407549CEQ36610052-FD7038B6-DAF9-4D5E-AF5D-5A2AB865826FQ36963605-8AA2F61A-9773-4BF6-8B31-52906F411F2AQ38749575-9512ACD2-6374-4CF8-8414-32633107ACEFQ38793244-01E78953-6E0A-4BF3-A9D2-5F47519671D4Q38816469-F885A724-432B-4B4E-BDB3-95BB463E7FA0Q38864070-A17BE9CF-434A-40B9-98DE-19F37B3F1A7BQ41636930-A09FA68E-1D41-4C9A-8B3E-F33DC5355B91Q47855170-0C17DB4D-B4F2-4FC4-B7EF-EC2E7F8DE518Q52310220-3B7F2073-BF16-4382-98B3-E6FEE4E24BDBQ52336242-F8121A9F-4FE4-48D4-AD13-EEEEDFA284DEQ52651080-B38EE372-7FF0-42AB-BCA9-945F08D6115EQ57117154-F33BA983-878A-474B-A20E-E1527350A60D
P2860
Loss of p53 attenuates the contribution of IL-6 deletion on suppressed tumor progression and extended survival in Kras-driven murine lung cancer
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Loss of p53 attenuates the con ...... Kras-driven murine lung cancer
@ast
Loss of p53 attenuates the con ...... Kras-driven murine lung cancer
@en
Loss of p53 attenuates the con ...... Kras-driven murine lung cancer
@nl
type
label
Loss of p53 attenuates the con ...... Kras-driven murine lung cancer
@ast
Loss of p53 attenuates the con ...... Kras-driven murine lung cancer
@en
Loss of p53 attenuates the con ...... Kras-driven murine lung cancer
@nl
prefLabel
Loss of p53 attenuates the con ...... Kras-driven murine lung cancer
@ast
Loss of p53 attenuates the con ...... Kras-driven murine lung cancer
@en
Loss of p53 attenuates the con ...... Kras-driven murine lung cancer
@nl
P2093
P2860
P3181
P1433
P1476
Loss of p53 attenuates the con ...... Kras-driven murine lung cancer
@en
P2093
Chuanhao Tang
Jicheng Chen
Jishuai Zhang
Xiaohong Tan
Xuan Cheng
Yanxiao Wang
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0080885
P407
P577
2013-01-01T00:00:00Z